Top News

Merck and Moderna logos displayed on a white background

RESEARCH

16 Jan 2026

mRNA Developers Regroup After Trial Setbacks

After late-stage failures, mRNA leaders narrow pipelines, double down on vaccines and cancer, and adopt tougher capital discipline

mRNA vaccine vial on medical documents with pills, syringe, and stethoscope

MARKET TRENDS

5 Feb 2026

mRNA Deals Push the Industry Beyond Vaccines

Biotech executives mark a major corporate milestone during a Nasdaq ceremony

PARTNERSHIPS

20 Jan 2026

GSK’s $2.2B Bet Signals a New Phase in Allergy Drug Races

Latest News

TECHNOLOGY
18 Feb 2026
How the Cloud Powers the Next mRNA Breakthrough
INSIGHTS
16 Feb 2026
Can Europe Win the mRNA Cancer Race?
REGULATORY
12 Feb 2026
FDA Refusal-to-File Resets mRNA Flu Strategy
INNOVATION
11 Feb 2026
Britain’s Bet On Better RNA Factories

Moderna and Recordati Bet on mRNA Beyond Vaccines

PARTNERSHIPS

10 Feb 2026

Moderna and Recordati partner on an mRNA therapy for propionic acidemia, combining resources to accelerate development

3D illustration of mRNA strands representing emerging in-vivo cancer cell therapy technology

INNOVATION

2 Jun 2025

mRNA Rewrites the Rules of Cancer Cell Therapy

Myeloid's in-body mRNA tech aims to make cancer treatment faster, cheaper, and more widely available.

7 8

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.